Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Unknown 1

Sponsor Class

OTHER 544NIH 170NETWORK 140INDUSTRY 43OTHER_GOV 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Sleep Initiation and Maintenance Disorders 1Rectal Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 49Capecitabine 42Radiotherapy 33Oxaliplatin 33Gemcitabine 33apatinib 32Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 20Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16Radiation 15camrelizumab 14S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Filgrastim × Clear all
NCT07192770 2026-02-20

GCSF-PAIN

Ankara Etlik City Hospital

Completed
225 enrolled

Depression, Fatigue, Sleep Initiation and Maintenance Disorders

NCT01164345 2015-12-03

Mozobil for Autologous Stem Cell Mobilization

Sheba Medical Center

Phase 2 Completed
20 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT02275663 2015-01-06

Azacytidine Plus FLAG for Relapsed or Refractory AML

King Fahad Medical City

Phase 2 Unknown
37 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00557102 2012-12-11

ERBIFORT

National Cancer Institute, France

Phase 2 Completed
24 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡